The Imperial College Academic Health Science Centre (AHSC) seminar series returns for a second year with an event on innovations in foetal medicine.
This will be the first of three events that will bring together experts from Imperial College London and Imperial College Healthcare NHS Trust to showcase the work of the AHSC.
The first event will be held on Monday 30 October at Hammersmith Hospital from 12.30. It will focus on pioneering treatments and technologies to improve the health of pregnant women and their babies.
The presentation will be jointly delivered by Dr Niamh Nowlan, senior lecturer at the College, and Professor Waljit Dhillo, Professor of Endocrinology at the College and consultant endocrinologist at the Trust.
Dr Nowlan will speak about her research on how abnormal fetal movements in the womb can impact the formation of joints. Dr Nowlan will also discuss a fetal movement sensor she has developed in collaboration with colleagues at the College and the Trust to measure and monitor infants’ movements throughout pregnancy. The aim is to detect and treat joint conditions such as hip dysplasia at an earlier stage, as well as help to prevent stillbirths.
Professor Dhillo will discuss how he has used a natural hormone found in the body called kisspeptin to safely trigger ovulation in women who are at risk of experiencing complications during IVF treatment. 63 babies have been born as a result of this treatment.